RB

Rekha Bansal

Active Director Director DIN 00892972
DIN 00892972 First appointment Jan 1989 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Jan 1989
Shareholding value •••• Premium profile

About Rekha Bansal

Data last updated:

Rekha Bansal is a Director at Medikay Pharma Private Limited (since 1989). The company operates in Pharma. Medikay Pharma Private Limited reported revenue of ₹33.6 Lakh (FY 2025).

DIN 00892972
Primary Designation Director
Industry Pharma
First Appointment 13 Jan 1989
Oldest Company Age 37 yrs
Largest company Medikay Pharma Private Limited · ₹33.6 Lakh (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Medikay Pharma Private Limited U74899DL1989PTC034652
Director13 Jan 19891989₹33.6 Lakh (FY 2025)Active

Board colleagues of Rekha Bansal

NameDINCompanyDesignation
Vir Sain Bansal00893034Medikay Pharma Private LimitedDirector

Directorship timeline

Open interactive timeline →
Medikay Pharma Private Limited
Premium access

Shareholding and investment profile for Rekha Bansal

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Rekha Bansal

Rekha Bansal currently holds 1 directorship: Medikay Pharma Private Limited (Director, since 13 Jan 1989, revenue ₹33.6 Lakh (FY 2025)).

Rekha Bansal was first appointed on 13 Jan 1989 as Director at Medikay Pharma Private Limited.

The current boards of Rekha Bansal's companies include Vir Sain Bansal (Medikay Pharma Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available